Have you been lingering on what else is going on within the field of atherosclerosis research after this year’s Scientific Sessions in American Heart Association? You might want to check out Vascular Discovery 2022, a 2 ½-day meeting, which is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology, the Peripheral Vascular Disease Council, and the Council on Genomic and Precision Medicine, in cooperation with and the Society for Vascular Surgery’s Vascular Research Initiatives Conference (Flyer on the right).
What is the conference about?
The primary goal of the Vascular Discovery: From Genes to Medicine Scientific Sessions is to provide a forum for the timely exchange of information about new and emerging scientific research in lipids and lipoproteins, arteriosclerosis, thrombosis, vascular biology, genomics, precision medicine, peripheral vascular disease, and vascular surgery.
One of the long-standing objectives of this conference is to provide a unique platform for colleagues to build valuable networks, establish potential collaborations and promote early career scientists via providing role model inspirations and mentorship opportunities. The advantages of direct social interactions are indisputable, especially when it comes to build meaningful relationships. This year’s Vascular Discovery will be held in-person in Seattle. It will bring colleagues from worldwide, share groundbreaking science and bridge different disciplines in a classic old fashion way.
Who should attend?
This event will appeal to scientists and clinicians in cardiovascular medicine, cardiovascular research, thrombosis research, clinical cardiology, molecular/cellular biology, vascular biology, vascular medicine, vascular surgery, endocrinology, genetics, functional genomics, hematology, immunology, nutrition, and physiology.
Past highlights and feature events
While the planning committee is finalizing the abstracts and awardees, we can take a glimpse of what happened in 2021, which will shed some lights into the 2022 scientistic sessions. Vascular Discovery presented a virtual experience to the attendees in 2021, because of COVID pandemics. Since COVID has been the primary attention in public and scientific communities the past couple years, one of the important focuses of Vascular Discovery 2021 is on understanding how COVID-19 affects vascular systems, to identify who and when to treat patients in vascular research and clinical trials. Other important discussions are on identifying new approaches to understand the pathophysiology of atherosclerosis via risk factor identifications, and a distinguished lecture was presented by Marlene Rabinovitch, M.D. on multiple approaches of identifying a therapeutic target for treating pulmonary hypertension. More highlights are shown in the American Heart Association website1.
Are you excited about attending this year’s in-person Vascular Discovery: from Genes to Medicine Scientific Sessions in Seattle? Stay tuned on the latest programming of 2022, which hopefully will be finalized and released in early March.
1. American Heart Association. Science News 2021. https://professional.heart.org/en/meetings/vascular-discovery-from-genes
“The views, opinions, and positions expressed within this blog are those of the author(s) alone and do not represent those of the American Heart Association. The accuracy, completeness, and validity of any statements made within this article are not guaranteed. We accept no liability for any errors, omissions, or representations. The copyright of this content belongs to the author and any liability with regards to infringement of intellectual property rights remains with them. The Early Career Voice blog is not intended to provide medical advice or treatment. Only your healthcare provider can provide that. The American Heart Association recommends that you consult your healthcare provider regarding your health matters. If you think you are having a heart attack, stroke, or another emergency, please call 911 immediately.”